Accedi a banche dati online | Convegnodetail
Anteprima di stampa
 
 

BCMA Targeted Therapies

Evvnt Promotion / evvnt
Archivio
-
21.06.2021 - 23.06.2021  Online
Time: 09:00 - 16:00
 
Temi della conferenza
Targeting BCMA with therapeutics such as ADCs, bispecific T-cell engagers (BiTEs) and CAR-T therapies within Multiple Myeloma has huge potential. The race for an approval within the crowded BCMA space has been hotly contested in recent years, and despite GSK's ADC, Blenrep, gaining approval in 2020 first, BCMA-targeted CAR-T and BiTe therapies continue to find their place.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Speakers: Adam Cohen, Assistant Professor - Medicine, University of Pennsylvania, Andreas Pahl, Chied Scientific Officer, Heidelbeg Pharma, David DiLillo, Assoc. Director, Immuno-Oncology, Regeneron and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/727512-2?pid=4832
Mr. Customer Service
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 1799.0 - USD 3237.0
I partecipanti attesi
1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

European Health Forum GasteinAGEM - Arbeitsgemeinschaft Ethnologie und MedizinAMREF - African Medical and Research FoundationHilfswerk AustriaAlumni Club Medizinische Universität WienCenter of ExcellenceÄrzte der WeltEuropean Public Health Association (EUPHA)